Skip to main content

Table 2 Characteristics of studies included in the 5-year survival meta-analysis

From: Prognostic significance of CD44V6 expression in osteosarcoma: a meta-analysis

Study Year Age (median) Assay kit No. of patients Method CD44V6 cut-off CD44V6 positive CD44V6 negative
Metastasis Total Metastasis Total
Deng et al. 2013 18.3 ZSGB-BIO 90 IHC >6 score 56 59 20 31
Kuryu et al. 1999 19 R&D 39 IHC >10 % 14 18 9 21
Lin et al. 2002 22 Maixin 70 IHC >2 score 58 64 4 6
Zhu et al. 2014 25 ZSGB-BIO 66 IHC >1 score 53 56 6 10